Human medicines European public assessment report (EPAR): Comirnaty, COVID-19 mRNA vaccine, Date of authorisation: 21/12/2020, Revision: 62, Status: Authorised
Enpr-EMA priority activities
Emergency Task Force (ETF) recommendations
ETF recommends updating COVID-19 vaccines to target XFG variant
EMA recommendation to update the antigenic composition of authorised COVID-19 vaccines for 2026-2027
Need for maximum residue limit (MRL) evaluation for biological substances - Scientific guideline
List of centrally authorised products with safety-related changes to the product information
Scientific advice for high-risk medical devices
Concept paper on the need for revision of the guideline on the development of medicinal products for the treatment of smoking
Quality of medicines: questions and answers - Part 2